Furthermore, the expression of NTF3 was significantly lower in HCC subgroups stratified by age, sex, nodal metastasis status, cancer stage, tumor protein P53 (TP53) mutation status and promoter methylation level (Figure 2). This evidence concerns the gene TP53 and hepatocellular carcinoma.